Elanco Animal Health (ELAN) Competitors $11.63 -0.19 (-1.61%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ELAN vs. TEVA, BGNE, MRNA, VTRS, SMMT, GMAB, RDY, SRPT, CTLT, and PCVXShould you be buying Elanco Animal Health stock or one of its competitors? The main competitors of Elanco Animal Health include Teva Pharmaceutical Industries (TEVA), BeiGene (BGNE), Moderna (MRNA), Viatris (VTRS), Summit Therapeutics (SMMT), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Sarepta Therapeutics (SRPT), Catalent (CTLT), and Vaxcyte (PCVX). These companies are all part of the "pharmaceutical products" industry. Elanco Animal Health vs. Teva Pharmaceutical Industries BeiGene Moderna Viatris Summit Therapeutics Genmab A/S Dr. Reddy's Laboratories Sarepta Therapeutics Catalent Vaxcyte Elanco Animal Health (NYSE:ELAN) and Teva Pharmaceutical Industries (NYSE:TEVA) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, community ranking, risk and valuation. Which has more risk and volatility, ELAN or TEVA? Elanco Animal Health has a beta of 1.41, meaning that its stock price is 41% more volatile than the S&P 500. Comparatively, Teva Pharmaceutical Industries has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Which has higher valuation and earnings, ELAN or TEVA? Teva Pharmaceutical Industries has higher revenue and earnings than Elanco Animal Health. Teva Pharmaceutical Industries is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElanco Animal Health$4.45B1.29-$1.23B$0.4029.08Teva Pharmaceutical Industries$16.77B1.49-$559M-$0.85-25.99 Is ELAN or TEVA more profitable? Elanco Animal Health has a net margin of 4.60% compared to Teva Pharmaceutical Industries' net margin of -5.73%. Teva Pharmaceutical Industries' return on equity of 42.92% beat Elanco Animal Health's return on equity.Company Net Margins Return on Equity Return on Assets Elanco Animal Health4.60% 6.78% 3.03% Teva Pharmaceutical Industries -5.73%42.92%7.25% Does the MarketBeat Community prefer ELAN or TEVA? Teva Pharmaceutical Industries received 1190 more outperform votes than Elanco Animal Health when rated by MarketBeat users. Likewise, 67.81% of users gave Teva Pharmaceutical Industries an outperform vote while only 54.37% of users gave Elanco Animal Health an outperform vote. CompanyUnderperformOutperformElanco Animal HealthOutperform Votes13754.37% Underperform Votes11545.63% Teva Pharmaceutical IndustriesOutperform Votes132767.81% Underperform Votes63032.19% Does the media refer more to ELAN or TEVA? In the previous week, Teva Pharmaceutical Industries had 22 more articles in the media than Elanco Animal Health. MarketBeat recorded 27 mentions for Teva Pharmaceutical Industries and 5 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 0.71 beat Teva Pharmaceutical Industries' score of 0.61 indicating that Elanco Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elanco Animal Health 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teva Pharmaceutical Industries 12 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of ELAN or TEVA? 97.5% of Elanco Animal Health shares are owned by institutional investors. Comparatively, 54.0% of Teva Pharmaceutical Industries shares are owned by institutional investors. 0.6% of Elanco Animal Health shares are owned by company insiders. Comparatively, 0.6% of Teva Pharmaceutical Industries shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts rate ELAN or TEVA? Elanco Animal Health currently has a consensus price target of $16.71, indicating a potential upside of 43.72%. Teva Pharmaceutical Industries has a consensus price target of $20.88, indicating a potential downside of 5.50%. Given Elanco Animal Health's higher probable upside, equities analysts plainly believe Elanco Animal Health is more favorable than Teva Pharmaceutical Industries.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Elanco Animal Health 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25Teva Pharmaceutical Industries 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75 SummaryTeva Pharmaceutical Industries beats Elanco Animal Health on 10 of the 18 factors compared between the two stocks. Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Get Elanco Animal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELAN vs. The Competition Export to ExcelMetricElanco Animal HealthPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$5.75B$6.57B$5.02B$19.19BDividend YieldN/A3.09%4.87%3.57%P/E Ratio29.0810.55135.2041.24Price / Sales1.29194.011,120.3117.58Price / Cash5.4557.1640.5821.28Price / Book0.925.104.755.32Net Income-$1.23B$151.51M$118.50M$989.67M7 Day Performance-3.80%-2.16%-1.83%-3.59%1 Month Performance-13.47%-2.91%12.27%-2.48%1 Year Performance-16.99%13.93%31.72%13.87% Elanco Animal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELANElanco Animal Health3.7675 of 5 stars$11.63-1.6%$16.71+43.7%-17.0%$5.84B$4.45B29.089,300TEVATeva Pharmaceutical Industries1.8805 of 5 stars$16.77+1.6%$19.67+17.3%+112.2%$19.00B$16.77B-19.7937,851Analyst DowngradeOptions VolumeNews CoverageBGNEBeiGene2.6115 of 5 stars$176.95-1.3%$253.69+43.4%+0.7%$17.24B$2.46B-21.7710,600MRNAModerna4.2664 of 5 stars$41.63-0.5%$79.50+91.0%-54.3%$16.02B$5.06B-7.195,600Analyst DowngradeVTRSViatris2.0581 of 5 stars$12.74+0.9%$13.67+7.3%+19.8%$15.21B$15.05B-17.0738,000News CoverageSMMTSummit Therapeutics3.2652 of 5 stars$18.21+2.1%$33.33+83.0%+636.9%$13.43B$700,000.00-63.68105News CoverageGMABGenmab A/S4.2355 of 5 stars$20.21+0.2%$45.20+123.7%-33.5%$13.37B$19.84B19.582,204Positive NewsHigh Trading VolumeRDYDr. Reddy's Laboratories1.8457 of 5 stars$14.76+2.1%$17.00+15.2%+15.8%$12.32B$299.87B22.9527,048Analyst DowngradeNews CoverageSRPTSarepta Therapeutics4.8116 of 5 stars$127.00+2.7%$178.71+40.7%+31.8%$12.13B$1.64B98.971,314Analyst ForecastPositive NewsCTLTCatalent2.7804 of 5 stars$63.47+0.6%$63.40-0.1%N/A$11.52B$4.38B-27.9116,900High Trading VolumePCVXVaxcyte1.6049 of 5 stars$90.74+3.4%$147.50+62.6%+45.4%$11.31BN/A-19.07160Analyst ForecastInsider Trade Related Companies and Tools Related Companies TEVA Competitors BGNE Competitors MRNA Competitors VTRS Competitors SMMT Competitors GMAB Competitors RDY Competitors SRPT Competitors CTLT Competitors PCVX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ELAN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elanco Animal Health Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Elanco Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
